melatonin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on malondialdehyde (circulating)
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“Also, the MLT group demonstrated marginal reduction in MDA compared to placebo group (F = 3.046, p = 0.092, partial η2 = 0.095), revealing a trend towards decreased oxidative stress that did not reach statistical significance.”
Quoted verbatim from Evaluating the antioxidant and anti-inflammatory effect of melatonin in pediatric hemodialysis patients: a randomized, placebo-controlled trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 5 mg oral melatonin once daily 1 h before bedtime for 12 weeks
- Population
- children on chronic haemodialysis; primary endpoint, ANCOVA adjusted for baseline MDA and antihypertensive use; serum MDA by ELISA
Evaluating the antioxidant and anti-inflammatory effect of melatonin in pediatric hemodialysis patients: a randomized, placebo-controlled trial.2026PMID:41565787Permalink
Keep reading
- Everything the graph holds on melatonin
- Every compound studied against Malondialdehyde (circulating)
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3R2JMQ36NNA29QDT7N5TJ4B